CONMED Corp (CNMD) insider trading
Every open-market stock purchase and sale by CONMED Corp executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.
Insider activity at a glance
- Insiders sold $161K over the last 12 months (2 sales). No open-market buys.
- Last insider buy: David M Bronson (Director), $97.3K, 2 years ago.
Last 12 months: insiders bought $0 (0 buys) and sold $161K (2 sales). Last close $49.44 on Oct 22, 2026.
Recent CNMD insider trades
| Date | Insider | Trade | Value |
|---|---|---|---|
| Sep 8, 2026 | Kim Kelderman (Director) | Bought (not open market) | — |
| Jul 15, 2026 | John E Gallagher (CFO) | Bought (not open market) | — |
| Jul 15, 2026 | John E Gallagher (CFO) | Bought (not open market) | — |
| Jul 15, 2026 | John E Gallagher (CFO) | Bought (not open market) | — |
| Jul 1, 2026 | Celine Christine Martin (Director) | Bought (not open market) | — |
| Jul 1, 2026 | Jeffrey B. Mirviss (Director) | Bought (not open market) | — |
| Jun 2, 2026 | David M. Bronson (Director) | Bought (not open market) | — |
| Jun 2, 2026 | Charles Farkas (Director) | Bought (not open market) | — |
| Jun 2, 2026 | LaVerne H Council (Director) | Bought (not open market) | — |
| Jun 2, 2026 | Mark Kaye (Director) | Bought (not open market) | — |
| Jun 2, 2026 | Barbara J Schwarzentraub (Director) | Bought (not open market) | — |
| Jun 1, 2026 | Kim Kelderman (Director) | Bought (not open market) | — |
| Jun 1, 2026 | LaVerne H Council (Director) | Bought (not open market) | — |
| Jun 1, 2026 | Charles Farkas (Director) | Bought (not open market) | — |
| Jun 1, 2026 | David M. Bronson (Director) | Bought (not open market) | — |
| Jun 1, 2026 | Barbara J Schwarzentraub (Director) | Bought (not open market) | — |
| Jun 1, 2026 | Mark Kaye (Director) | Bought (not open market) | — |
| Apr 1, 2026 | Pat Beyer (CEO) | Bought (not open market) | — |
| Mar 6, 2026 | Brent Lalomia (VP) | Sold (not open market) | $1K |
| Mar 6, 2026 | Brent Lalomia (VP) | Bought (not open market) | — |
| Mar 2, 2026 | Hollie K Foust (General Counsel) | Bought (not open market) | — |
| Mar 2, 2026 | Hollie K Foust (General Counsel) | Bought (not open market) | — |
| Mar 2, 2026 | Matthew Schabacker (VP) | Bought (not open market) | — |
| Mar 2, 2026 | Matthew Schabacker (VP) | Bought (not open market) | — |
| Mar 2, 2026 | Brent Lalomia (VP) | Bought (not open market) | — |
Who's trading CNMD
- Kim Kelderman, Director: other filings, last Sep 8, 2026
- John E Gallagher, CFO: other filings, last Jul 15, 2026
- Jeffrey B. Mirviss, Director: other filings, last Jul 1, 2026
- Celine Christine Martin, Director: other filings, last Jul 1, 2026
- Mark Kaye, Director: other filings, last Jun 2, 2026
- David M. Bronson, Director: other filings, last Jun 2, 2026
- Barbara J Schwarzentraub, Director: other filings, last Jun 2, 2026
- LaVerne H Council, Director: other filings, last Jun 2, 2026
- Charles Farkas, Director: other filings, last Jun 2, 2026
- Pat Beyer, CEO: other filings, last Apr 1, 2026
- Brent Lalomia, President: other filings, last Mar 6, 2026
- John D. Ferrell, President: other filings, last Mar 2, 2026
- Hollie K Foust, General Counsel: other filings, last Mar 2, 2026
- Matthew Schabacker, VP: other filings, last Mar 2, 2026
- Peter K Shagory, VP: other filings, last Mar 2, 2026
Get free alerts when an insider at CONMED Corp files a new trade →